Changes in the metabolism of axillary lymph node cells as a predictor of regional metastasis in breast cancer

doi:10.5493/wjem.125128

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 3

This Article

(1)

(0)

(1)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Experimental Medicine

ISSN

2220-315X

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Exp Med. Sep 20, 2026; 16(3): 125128
Published online Sep 20, 2026. doi: 10.5493/wjem.125128

Table 1 Clinical and pathological characteristics of breast cancer patients

Breast cancer characteristics	n (%)
Т stage
Т1b	4 (5.8)
T1c	42 (60.9)
Т2	23 (33.3)
N stage
N0	45 (65.1)
N1	14 (20.3)
N2	8 (11.6)
N3	2 (2.9)
Grade (G)
G1	9 (13.0)
G2	34 (49.3)
G3	26 (37.7)
Lymphovascular invasion
Absent	51 (73.9)
Present	18 (26.1)
Perineural invasion
Absent	59 (85.5)
Present	10 (14.5)
Intraductal component
Absent	57 (82.6)
Present	12 (17.4)
ER status
Negative	11 (15.9)
Positive	58 (84.1)
PR status
Negative	26 (37.7)
Positive	43 (62.3)
HER2 status
Negative	61 (88.4)
Positive	8 (11.6)
Molecular biological subtypes
Luminal A	34 (49.3)
Luminal B HER2-	23 (33.3)
Luminal B HER2+	4 (5.8)
Nonluminal HER2+	4 (5.8)
TNBC	4 (5.8)

ER: Estrogen receptor; HER2: Human epidermal growth factor receptor 2; PR: Progesterone receptor; TNBC: Triple-negative breast cancer.

Full Size Table

Citation: Senchukova MA, Ishemgulov AT, Letuta SN, Saidler NV, Tagabilev DG. Changes in the metabolism of axillary lymph node cells as a predictor of regional metastasis in breast cancer. World J Exp Med 2026; 16(3): 125128
URL: https://www.wjgnet.com/2220-315X/full/v16/i3/125128.htm
DOI: https://dx.doi.org/10.5493/wjem.125128

Senchukova MA, Ishemgulov AT, Letuta SN, Saidler NV, Tagabilev DG. Changes in the metabolism of axillary lymph node cells as a predictor of regional metastasis in breast cancer. World J Exp Med 2026; 16(3): 125128 [DOI: 10.5493/wjem.125128]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.